Page 1 | Search Results | The Journal of Immunology | American Association of Immunologists

1-13 of 13

Sort by

Sort Order Select

Journal Articles

NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype

Erik Ames, Robert J. Canter, Steven K. Grossenbacher, Stephanie Mac, Mingyi Chen, Rachel C. Smith, Takeshi Hagino, Jessica Perez-Cunningham, Gail D. Sckisel, Shiro Urayama, Arta M. Monjazeb, Ruben C. Fragoso, Thomas J. Sayers, William J. Murphy

J Immunol (2015) 195 (8): 4010–4019.

https://doi.org/10.4049/jimmunol.1500447

Published: 15 October 2015

View articletitled, NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype

Add to Citation Manager for NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype

Includes: Supplementary data

Journal Articles

Regulatory T Cells and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment Undergo Fas-Dependent Cell Death during IL-2/αCD40 Therapy

Jonathan M. Weiss, Jeff J. Subleski, Tim Back, Xin Chen, Stephanie K. Watkins, Hideo Yagita, Thomas J. Sayers, William J. Murphy, Robert H. Wiltrout

J Immunol (2014) 192 (12): 5821–5829.

https://doi.org/10.4049/jimmunol.1400404

Published: 15 June 2014

View articletitled, Regulatory T Cells and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment Undergo Fas-Dependent Cell Death during IL-2/αCD40 Therapy

Add to Citation Manager for Regulatory T Cells and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment Undergo Fas-Dependent Cell Death during IL-2/αCD40 Therapy

Includes: Supplementary data

Journal Articles

Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow

Rosalba Salcedo, Julie A. Hixon, Jimmy K. Stauffer, Rashmi Jalah, Alan D. Brooks, Tahira Khan, Ren-Ming Dai, Loretta Scheetz, Erin Lincoln, Timothy C. Back, Douglas Powell, Arthur A. Hurwitz, Thomas J. Sayers, Robert Kastelein, George N. Pavlakis, Barbara K. Felber, Giorgio Trinchieri, Jon M. Wigginton

J Immunol (2009) 182 (7): 4328–4338.

https://doi.org/10.4049/jimmunol.0800471

Published: 01 April 2009

View articletitled, Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow

Add to Citation Manager for Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow

Journal Articles

Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition

William H.D. Hallett, Erik Ames, Milad Motarjemi, Isabel Barao, Anil Shanker, David L. Tamang, Thomas J. Sayers, Dorothy Hudig, William J. Murphy

J Immunol (2008) 180 (1): 163–170.

https://doi.org/10.4049/jimmunol.180.1.163

Published: 01 January 2008

View articletitled, Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition

Add to Citation Manager for Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition

Journal Articles

Proteasome inhibition promotes tumor cell apoptosis by exogenous TRAIL without blocking anti-tumor immune effectors in vivo (50.6)

Anil Shanker, Alan D Brooks, Carlos A Tristan, John Wine, Thomas J Sayers

J Immunol (2007) 178 (1_Supplement): S91.

https://doi.org/10.4049/jimmunol.178.Supp.50.6

Published: 01 April 2007

View articletitled, Proteasome inhibition promotes tumor cell apoptosis by exogenous TRAIL without blocking anti-tumor immune effectors in vivo (50.6)

Add to Citation Manager for Proteasome inhibition promotes tumor cell apoptosis by exogenous TRAIL without blocking anti-tumor immune effectors in vivo (50.6)

Journal Articles

NK Cells Use NKG2D to Recognize a Mouse Renal Cancer (Renca), yet Require Intercellular Adhesion Molecule-1 Expression on the Tumor Cells for Optimal Perforin-Dependent Effector Function

Karen Abdool, Erika Cretney, Alan D. Brooks, Janice M. Kelly, Jeremy Swann, Anil Shanker, Earl W. Bere, Jr., Wayne M. Yokoyama, John R. Ortaldo, Mark J. Smyth, Thomas J. Sayers

J Immunol (2006) 177 (4): 2575–2583.

https://doi.org/10.4049/jimmunol.177.4.2575

Published: 15 August 2006

View articletitled, NK Cells Use NKG2D to Recognize a Mouse Renal Cancer (Renca), yet Require Intercellular Adhesion Molecule-1 Expression on the Tumor Cells for Optimal Perforin-Dependent Effector Function

Add to Citation Manager for NK Cells Use NKG2D to Recognize a Mouse Renal Cancer (Renca), yet Require Intercellular Adhesion Molecule-1 Expression on the Tumor Cells for Optimal Perforin-Dependent Effector Function

Journal Articles

Proteasome Inhibition to Maximize the Apoptotic Potential of Cytokine Therapy for Murine Neuroblastoma Tumors

Tahira Khan, Jimmy K. Stauffer, Rebecca Williams, Julie A. Hixon, Rosalba Salcedo, Erin Lincoln, Timothy C. Back, Douglas Powell, Stephen Lockett, Alma C. Arnold, Thomas J. Sayers, Jon M. Wigginton

J Immunol (2006) 176 (10): 6302–6312.

https://doi.org/10.4049/jimmunol.176.10.6302

Published: 15 May 2006

View articletitled, Proteasome Inhibition to Maximize the Apoptotic Potential of Cytokine Therapy for Murine Neuroblastoma Tumors

Add to Citation Manager for Proteasome Inhibition to Maximize the Apoptotic Potential of Cytokine Therapy for Murine Neuroblastoma Tumors

Journal Articles

Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8⁺ Cell Responses

William J. Murphy, Lisbeth Welniak, Timothy Back, Julie Hixon, Jeff Subleski, Naoko Seki, Jon M. Wigginton, Susan E. Wilson, Bruce R. Blazar, Anatoli M. Malyguine, Thomas J. Sayers, Robert H. Wiltrout

J Immunol (2003) 170 (5): 2727–2733.

https://doi.org/10.4049/jimmunol.170.5.2727

Published: 01 March 2003

View articletitled, Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8+ Cell Responses

Add to Citation Manager for Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8+ Cell Responses

Journal Articles

Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin

Naoko Seki, Alan D. Brooks, Clive R. D. Carter, Timothy C. Back, Erin M. Parsoneault, Mark J. Smyth, Robert H. Wiltrout, Thomas J. Sayers

J Immunol (2002) 168 (7): 3484–3492.

https://doi.org/10.4049/jimmunol.168.7.3484

Published: 01 April 2002

View articletitled, Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin

Add to Citation Manager for Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin

Journal Articles

The Restricted Expression of Granzyme M in Human Lymphocytes

Thomas J. Sayers, Alan D. Brooks, Jerrold M. Ward, Tomoaki Hoshino, William E. Bere, Gordon W. Wiegand, Janice M. Kelley, Mark J. Smyth

J Immunol (2001) 166 (2): 765–771.

https://doi.org/10.4049/jimmunol.166.2.765

Published: 15 January 2001

View articletitled, The Restricted Expression of Granzyme M in Human Lymphocytes

Add to Citation Manager for The Restricted Expression of Granzyme M in Human Lymphocytes

Journal Articles

IFN-γ-Dependent Delay of In Vivo Tumor Progression by Fas Overexpression on Murine Renal Cancer Cells

Jong-Keuk Lee, Thomas J. Sayers, Alan D. Brooks, Timothy C. Back, Howard A. Young, Kristin L. Komschlies, Jon M. Wigginton, Robert H. Wiltrout

J Immunol (2000) 164 (1): 231–239.

https://doi.org/10.4049/jimmunol.164.1.231

Published: 01 January 2000

View articletitled, IFN-γ-Dependent Delay of In Vivo Tumor Progression by Fas Overexpression on Murine Renal Cancer Cells

Add to Citation Manager for IFN-γ-Dependent Delay of In Vivo Tumor Progression by Fas Overexpression on Murine Renal Cancer Cells

Journal Articles

Molecular Mechanisms of Immune-Mediated Lysis of Murine Renal Cancer: Differential Contributions of Perforin-Dependent Versus Fas-Mediated Pathways in Lysis by NK and T Cells

Thomas J. Sayers, Alan D. Brooks, Jong-Keuk Lee, Robert G. Fenton, Kristin L. Komschlies, Jon M. Wigginton, Robin Winkler-Pickett, Robert H. Wiltrout

J Immunol (1998) 161 (8): 3957–3965.

https://doi.org/10.4049/jimmunol.161.8.3957

Published: 15 October 1998

View articletitled, Molecular Mechanisms of Immune-Mediated Lysis of Murine Renal Cancer: Differential Contributions of Perforin-Dependent Versus Fas-Mediated Pathways in Lysis by NK and T Cells

Add to Citation Manager for Molecular Mechanisms of Immune-Mediated Lysis of Murine Renal Cancer: Differential Contributions of Perforin-Dependent Versus Fas-Mediated Pathways in Lysis by NK and T Cells

Journal Articles

The Trophic Action of IL-7 on Pro-T Cells: Inhibition of Apoptosis of Pro-T1, -T2, and -T3 Cells Correlates with Bcl-2 and Bax Levels and Is Independent of Fas and p53 Pathways

Kyungjae Kim, Chong-kil Lee, Thomas J. Sayers, Kathrin Muegge, Scott K. Durum

J Immunol (1998) 160 (12): 5735–5741.

https://doi.org/10.4049/jimmunol.160.12.5735

Published: 15 June 1998

View articletitled, The Trophic Action of IL-7 on Pro-T Cells: Inhibition of Apoptosis of Pro-T1, -T2, and -T3 Cells Correlates with Bcl-2 and Bax Levels and Is Independent of Fas and p53 Pathways

Add to Citation Manager for The Trophic Action of IL-7 on Pro-T Cells: Inhibition of Apoptosis of Pro-T1, -T2, and -T3 Cells Correlates with Bcl-2 and Bax Levels and Is Independent of Fas and p53 Pathways

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype

Regulatory T Cells and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment Undergo Fas-Dependent Cell Death during IL-2/αCD40 Therapy

Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow

Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition

Proteasome inhibition promotes tumor cell apoptosis by exogenous TRAIL without blocking anti-tumor immune effectors in vivo (50.6)

NK Cells Use NKG2D to Recognize a Mouse Renal Cancer (Renca), yet Require Intercellular Adhesion Molecule-1 Expression on the Tumor Cells for Optimal Perforin-Dependent Effector Function

Proteasome Inhibition to Maximize the Apoptotic Potential of Cytokine Therapy for Murine Neuroblastoma Tumors

Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8⁺ Cell Responses

Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin

The Restricted Expression of Granzyme M in Human Lymphocytes

IFN-γ-Dependent Delay of In Vivo Tumor Progression by Fas Overexpression on Murine Renal Cancer Cells

Molecular Mechanisms of Immune-Mediated Lysis of Murine Renal Cancer: Differential Contributions of Perforin-Dependent Versus Fas-Mediated Pathways in Lysis by NK and T Cells

The Trophic Action of IL-7 on Pro-T Cells: Inhibition of Apoptosis of Pro-T1, -T2, and -T3 Cells Correlates with Bcl-2 and Bax Levels and Is Independent of Fas and p53 Pathways

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

Update search

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

This Feature Is Available To Subscribers Only